Skip to main content
European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation

Descrizione del progetto

Uno studio paneuropeo sulla sicurezza dei farmaci durante la gravidanza

Il progetto ConcePTION, finanziato dall’UE, si propone di stabilire un cambio di paradigma negli studi sulla sicurezza dei farmaci durante la gravidanza. Il consorzio include leader esperti per la gestione delle reti di partenariati pubblico-privati, la connessione a iniziative simili in altre parti del mondo e la rivalutazione dei dati provenienti da precedenti progetti della Commissione europea. Gli obiettivi del progetto includono l’istituzione di un ecosistema sostenibile non proprietario con sede nell’UE di parti interessate pubbliche e private, donne in gravidanza e ricercatori per generare e diffondere prove relative all’esposizione farmacologica durante la gravidanza e l’allattamento. I ricercatori impiegheranno modelli per la previsione del trasferimento dei farmaci all’interno del latte umano, analisi di dati di biobanche, quantificazione dei farmaci nel latte umano e raccolta di dati digitali e campioni direttamente da donne in stato di gravidanza.

Obiettivo

ConcePTION partners have united around a shared vision that we have a societal obligation to radically and rapidly reduce uncertainty about the safety of medication use in pregnancy and lactation.

What do we deliver? ConcePTION aims to create a paradigm shift in how we study medication safety in pregnancy. We will establish (1) a successful, sustainable open-science based EU non-proprietary ecosystem of public and private stakeholders, pregnant women and researchers to generate and disseminate timely and reliable evidence on drugs across maternal, neonatal and long term outcomes of medication exposure in pregnancy and breastfeeding (2) a catalogue with fully characterized data sources for rapid selection of suitable data sources; 3) operational, business, network, information and data governance models, (4) quality assured and tested methodological approaches, analytical tools and data platforms allowing for distributed analyses, (5) procedures and tools for collection of digital data and samples directly from pregnant women, (6) In vitro, in silico and in vivo models for prediction of drug transfer in human milk, (7) a biobank and analytical network for quantification of drug in human milk, (8) best practice documents endorsed by regulators and health authorities and (9) a web-based drug information knowledge bank.

How do we deliver? (1) Experienced leaders, able to manage challenging networks and public-public or public-private partnerships. (2) Defragmentation by connecting all key stakeholders and EU networks in this area. (3) Re-use of data, tools and foreground from prior European commission funded projects. (4) Connecting to leaders of similar initiatives in the USA, Canada, Asia and other parts of the world. (5) Systematic consensus & endorsement building. (6) Quality throughout as a precondition to trust the results and information by all users.

Meccanismo di finanziamento

RIA - Research and Innovation action

Coordinatore

UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Contribution nette de l'UE
€ 2 486 436,44
Indirizzo
HEIDELBERGLAAN 100
3584 CX Utrecht
Paesi Bassi

Mostra sulla mappa

Regione
West-Nederland Utrecht Utrecht
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
€ 2 581 436,45

Partecipanti (66)